[HTML][HTML] Levodopa-carbidopa intestinal gel in advanced Parkinson's: final results of the GLORIA registry

…, EH Danielsen, L Defebvre, V Delvaux, S Dethy… - Parkinsonism & related …, 2017 - Elsevier
Introduction This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa
intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine …

[PDF][PDF] Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy

…, D Wikler, P Damhaut, S Dethy… - Journal of Nuclear …, 1997 - Soc Nuclear Med
RESULTS In the total set of 93 tumor samples, tumor-to-cortex ratios calculated on MET-PET
and FDG-PET were highly positively correlated (Fig. 1, Spearman rho= 0.77, p< 0.0001). …

Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young

…, J Delbecq, G De Keulenaer, S Dethy… - Clinical neurology and …, 2013 - Elsevier
OBJECTIVE: In the Belgian Fabry Study (BeFaS), the prevalence of Fabry disease was
assessed in 1000 young patients presenting with stroke, unexplained white matter lesions or …

Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3 …

…, T Danaila, MF De Pandis, S Dethy… - The Lancet …, 2024 - thelancet.com
Background Conventional oral levodopa therapy for the treatment of Parkinson's disease
can be associated with variations in plasma concentrations. Levodopa infusion strategies …

PET findings in a brain abscess associated with a silent atrial septal defect

S Dethy, M Manto, A Kentos, D Konopnicki… - Clinical neurology and …, 1995 - Elsevier
Brain abscesses are classical complications of congenital heart disease (CHD) in children
and adolescents. This association is rarely observed in adults. We report a 46-year-old man …

Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease: methodology and 6-month to 1-year follow-up in 3 …

M Levivier, S Dethy, F Rodesch… - Stereotactic and …, 1997 - karger.com
In order to launch a new transplantation program for Parkinson''s disease (PD), we evaluated
the safety and efficacy of fetal ventral mesencephalic grafts in 3 patients with advanced PD. …

Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma.

S Dethy, S Goldman, S Blecic, A Luxen… - Journal of nuclear …, 1994 - europepmc.org
Three patients were examined using PET with L-methyl-11C-methionine (11C-methionine)
and 2-18F-fluoro-2-deoxy-D-glucose (FDG) 20 to 32 days after the occurrence of nontumoral …

Effects of the oral form of ondansetron on cerebellar dysfunction: a multi-center double-blind study

JC Bier, S Dethy, J Hildebrand, J Jacquy, M Manto… - Journal of …, 2003 - Springer
The aim of this study was to assess the efficacy and the safety of ondansetron administered
orally in patients with a cerebellar disorder. The study was a randomised, multi-center, …

Intestinal levodopa infusion: the Belgian experience

BA Pickut, C Van Der Linden, S Dethy… - Neurological …, 2014 - Springer
… Chris van der Linden and Sophie Dethy attest that they have no relevant financial disclosures
or relationships with people/organizations that may have inappropriately influenced the …

Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients

S Dethy, MA Laute, N Van Blercom… - Clinical …, 1997 - academic.oup.com
We used in vitro microdialysis-HPLC to determine l-3,4-dihydroxyphenylalanine (l-DOPA)
and its metabolites in plasma of patients with advanced Parkinson disease. Blood samples …